我在那里看病人 (1)
我的评论
选择研究
-
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia.
血液的进步
-
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.
Haematologica
-
FLT3 targeting in the modern era: from clonal selection to combination therapies.
International journal of hematology
4.9